Genistein protects dopaminergic neurons by inhibiting microglial activation

NeuroReport

Volumn 16, Issue 3, 2005, Pages 267-270

  Wang, Xijin ^a   Chen, Shengdi ^a,b   Ma, Guozhao ^a   Ye, Min ^a   Lu, Guoqiang ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

Dopaminergic neurodegeneration; Genistein; Inflammation; Isoflavone; Microglia; Parkinson's disease

Indexed keywords

DOPAMINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GENISTEIN; ISOFLAVONE; NITRIC OXIDE; SUPEROXIDE; TRITIUM; TUMOR NECROSIS FACTOR ALPHA; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; INFLAMMATION; MESENCEPHALON; MICROGLIA; NERVE CELL CULTURE; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIGENS, CD11B; CELLS, CULTURED; COCULTURE TECHNIQUES; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EMBRYO; ENZYME INHIBITORS; GENISTEIN; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; MESENCEPHALON; MICROGLIA; NEURONS; RATS; TRITIUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 14944340012     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200502280-00013     Document Type: Article

References (16)

1. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996; 19:312-318.
2. Gao HM, Jiang J, Wilson B, Zhang W, Hong JS, Liu B. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J Neurochem 2002; 81:1285-1297.
3. Liu B, Hong JS. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 2003; 304:1-7.
4. Liu B, Du L, Hong JS. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther 2000; 293:607-617.
5. Vegeto E, Bonincontro C, Pollio G, Sala A, Viappiani S, Nardi F et al. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci 2001; 21:1809-1818.
6. Gao HM, Hong JS, Zhang W, Liu B. Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. J Neurosci 2003; 23:1228-1236.
7. Bronstein DM, Perez-Otano I, Sun V, Mullis-Sawin SB, Chan J, Wu GC et al. Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res 1995; 704:112-116.
8. Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS. Regional difference in susceptibility to lipopolysaccharide induced neurotoxicity in the rat brain: role of microglia. J Neurosci 2000; 20:6309-6316.
9. Wang MJ, Lin WW, Chen HL, Chang YH, Ou HC, Kuo JS et al. Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation. Eur J Neurosci 2002; 16:2103-2112.
10. Le W, Rowe D, Xie W, Ortiz I, He Y, Appel SH. Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. J Neurosci 2001; 21:8447-8455.
11. Trieu VN, Uckun FM. Genistein is neuroprotective in murine models of familial amyotrophic lateral sclerosis and stroke. Biochem Biophys Res Commun 1999; 258:685-688.
12. Sonee M, Sum T, Wang C, Mukherjee SK. The soy isoflavone, genistein, protects human cortical neuronal cells from oxidative stress. Neurotoxicology 2004; 25:885-891.
13. Liu Y, Qin L, Li G, Zhang W, An L, Liu B et al. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglia-1 activation. J Pharmacol Exp Ther 2003; 305:212-218.
14. Zhou HF, Niu DB, Xue B, Li FQ, Liu XY, He QH et al. Triptolide inhibits TNF-alpha, IL-1 beta and NO production in primary microglial cultures. Neuroreport 2003; 14:1091-1095.
15. Kong LY, McMillian MK, Maronpot R, Hong JS. Protein tyrosine kinase inhibitors suppress the production of nitric oxide in mixed glia, microglia-enriched or astrocyte-enriched cultures. Brain Res 1996; 729:102-109.
16. Kong LY, Lai C, Wilson BC, Simpson JN, Hong JS. Protein tyrosine kinase inhibitors decrease lipopolysaccharide-induced proinflammatory cytokine production in mixed glia, microglia-enriched or astrocyte-enriched cultures. Neurochem Int 1997; 30:491-497.